info@seagull-health.com
SeagullHealth
语言:
search
new
What are the Indications for Amlodipine?
512
Article source: Seagull Pharmacy
Dec 17, 2025

Amlodipine is a long-acting calcium channel blocker that plays an important role in the treatment of cardiovascular diseases. Its orally disintegrating tablet (ODT) formulation further enhances the convenience of administration through a unique manufacturing process, making it particularly suitable for patients with dysphagia or those requiring rapid onset of action.

What are the Indications for Amlodipine?

Hypertension Treatment

Amlodipine orally disintegrating tablets are indicated for the treatment of patients with hypertension at all stages, either as monotherapy or in combination with other antihypertensive drugs.

Its antihypertensive mechanism stems from a direct effect on vascular smooth muscle: by inhibiting calcium ion influx, it effectively reduces peripheral vascular resistance.

Chronic Stable Angina Pectoris

For patients diagnosed with chronic stable angina pectoris, this product can significantly alleviate exercise-induced angina symptoms.

Its mechanism of action includes reducing cardiac afterload and myocardial oxygen consumption without affecting heart rate, resulting in a favorable safety profile.

Vasospastic Angina Pectoris

This product has a definite therapeutic effect on variant angina pectoris.

It restores blood perfusion by inhibiting coronary artery spasm.

It is important to note that caution should be exercised when administering this drug to patients with severe aortic stenosis. Exacerbation of angina pectoris has been occasionally reported when initiating calcium channel blocker therapy, requiring close monitoring.

Dosage Forms, Specifications and Characteristics of Amlodipine

Dosage Form Design and Specifications

Amlodipine orally disintegrating tablets adopt oral disintegration technology and are available in three specifications: 2.5 mg, 5 mg and 10 mg (all calculated as amlodipine).

Its unique advantage is that it can disintegrate rapidly in the oral cavity without the need for water, and is swallowed and absorbed via saliva, which greatly improves medication compliance.

Appearance Identification Characteristics

The 2.5 mg tablet is a white, round, biconvex tablet engraved with "ADP2.5" and "ODT".

The 5 mg tablet is light yellow and marked with "ADP5".

The 10 mg tablet is pink and labeled with "ADP10".

Composition

Active ingredient: Amlodipine besylate.

Excipients: The tablet also contains a variety of excipients, including hydroxypropyl cellulose (stabilizer), iron oxide red (colorant for 10 mg tablets), iron oxide yellow (colorant for 5 mg tablets), magnesium stearate (lubricant), menthol (flavoring agent), silicified microcrystalline cellulose (disintegrant) and sucralose (sweetener).

Storage Method for Amlodipine

Environmental Requirements

This product should be stored at room temperature between 20°C and 25°C (68°F and 77°F), with short-term storage permitted in the range of 15°C to 30°C (59°F to 86°F).

Special attention should be paid to light protection to avoid ingredient degradation caused by direct sunlight.

Container Selection

It must be stored in a sealed, light-resistant dedicated container.

In daily management, the medicine should not be placed in high-humidity places such as bathrooms to prevent moisture absorption that may affect its efficacy.

Special Precautions

Ensure the bottle cap is tightly closed after opening to avoid moisture absorption.

Tablets of different specifications should be stored separately to prevent confusion.

For household storage, place the medicine in a safe location out of the reach of children to avoid accidental ingestion.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
Where to Purchase Amlodipine
Amlodipine is a long-acting calcium channel blocker widely used in the treatment of hypertension, chronic stable angina pectoris, and vasospastic angina pectoris. As a prescription drug, its standardi...
Adverse Reactions of Pemigatinib (Pemazyre)
Pemigatinib (Pemazyre) is a targeted therapy indicated for the treatment of specific types of cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FGFR1 rearrangement.Adverse Reactions of Pemi...
What are the Precautions for Taking Pemigatinib (Pemazyre)?
Pemigatinib (Pemazyre) is an important targeted therapy for specific gene mutations, playing a pivotal role in the treatment of advanced cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FG...
What are the Indications for Pemigatinib (Pemazyre)?
Pemigatinib (Pemazyre) is an innovative kinase inhibitor. By specifically targeting the fibroblast growth factor receptor (FGFR) pathway, it provides a precision treatment option for patients with mal...
Dosage and Administration of Amlodipine - Recommended Doses
Amlodipine is a long-acting dihydropyridine calcium channel blocker, widely used in the treatment of hypertension and angina pectoris.Dosage and Administration of Amlodipine - Recommended DosesDosage ...
Dosage and Administration of Pemigatinib (Pemazyre) - Recommended Doses
Pemigatinib (Pemazyre) is a targeted therapy for specific genetic abnormalities, mainly indicated for the treatment of cholangiocarcinoma with FGFR2 genetic abnormalities and myeloid/lymphoid neoplasm...
Where to Purchase Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an important medication for the treatment of type 2 diabetes mellitus. Patients pay close attention to issues such as the l...
What are the Indications for Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a novel fixed-dose combination antihyperglycemic medication. It integrates two hypoglycemic ingredients with distinct mechanisms of actio...
Related Articles
Contraindications and Special Populations of Brensocatib Tablets
The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but careful assessment of risks and benefits is still required in patients with special physi...
Dosage and Administration of Isatuximab Injection (Sarclisa)
Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must be equipped with immediately available emergency equipment and medical support to man...
Indications and Dosage of Tepotinib
Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer harboring MET exon 14 skipping mutations.I. Indications and Patient Selection1. Applicable ...
Dosage and Administration of Zidesamtinib
Before the first administration of Ziditnib, the following baseline assessments must be completed: serum creatine phosphokinase level, electrocardiogram, blood electrolytes (potassium, magnesium, calc...
Indications and Dosage and Administration of Ripretinib
Ripretinib is a kinase inhibitor specifically indicated for adult patients with advanced gastrointestinal stromal tumors who have previously received three or more kinase inhibitors.I. Indications and...
Contraindications and Medication in Special Populations of Ripretinib
Ripretinib does not list any absolute contraindications in its prescribing information, but there are clear usage restrictions or risks for specific physiological states and populations.I. Clear Contr...
Adverse Reactions of Ripretinib
Unlike traditional inhibition that targets the active site of a single kinase, ripretinib modulates the kinase "switch" conformation to suppress aberrant kinase signaling of KIT and PDGFRA, ...
Contraindications and Medication in Special Populations of Etoricoxib
Etoricoxib is effective for pain relief, but due to its cardiovascular and gastrointestinal risks, there are clear contraindications for its use.I. Absolute contraindications: who must not use it1. Al...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved